An alternative explanation would be that lower circulating levels of IL-8 may favor a shift in the microbial composition present in the respiratory system, favoring the proliferation of a relatively beneficial microbiota that may contribute to attenuating lung disease progression. This evidence concerns the gene CXCL8 and lung disorder.